Skip to content

Nasdaq biocept

HomeMoretti26952Nasdaq biocept
19.10.2020

13/05/2020 16/07/2020 24/07/2020 Anyone researching Biocept, Inc. (NASDAQ:BIOC) might want to consider the historical volatility of the share price.Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories.

16/05/2020

Biocept, Inc. Common Stock (BIOC) Pre-Market Stock Quotes - Nasdaq offers pre -market quotes and pre-market activity data for US and global markets. Biocept (NASDAQ: BIOC) shares are trading higher on Thursday after the company announced an agreement with Aegea Biotechnologies to develop new,   Biocept (NASDAQ: BIOC) shares are trading higher on Thursday after the company announced an agreement with Aegea Biotechnologies to develop new,   Stock analysis for Biocept Inc (BIOC:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Results 1 - 10 of 296 4, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians  Company Operator: 858.320.8200. Fax: 858.320.8225. Email: info@biocept.com. About Biocept · Patients / Caregivers · Healthcare Providers · Partners · Pay My 

27/07/2020

Jun 22, 2020 · Biocept (NASDAQ:BIOC) announces the availability of 10,000 nasopharyngeal specimen collection kits for RT-PCR testing for COVID-19 for physician ordering. Collected specimens will be shipped May 13, 2020 · Biocept, Inc. (NASDAQ: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with 1 day ago · Biocept (BIOC +15.2%) and Aegea Biotechnologies agree to develop a highly sensitive PCR-based assay designed by Aegea for detecting the COVID-19 virus. The collaboration will leverage Biocept's Apr 24, 2020 · Biocept (NASDAQ:BIOC) has filed a prospectus for a $100M mixed shelf offering. Shares down 2% after hours.

Aug 07, 2020 · Biocept, Inc., belongs to Healthcare sector and Diagnostics & Research industry. The company’s Market capitalization is $144.88M with the total Outstanding Shares of 1. On 06-08-2020 (Thursday), BIOC stock construct a change of 27.47 in a total of its share price and finished its trading at 1.14. Profitability Ratios (ROE, ROA, ROI):

23/07/2020

Biocept Inc (NASDAQ:BIOC) shares gapped up before the market opened on Tuesday . The stock had previously closed at $0.75, but opened at $0.71. Biocept shares last traded at $0.71, with a volume of 513,470 shares changing hands. BIOC has been the subject of several recent research reports. Brookline Capital Management started coverage on Biocept […]

Biocept, Inc. is an oncology laboratory service company, which focuses on the development and marketing of novel laboratory products in the detection of rare cells to include circulating tumor cells. It develops and commercializes proprietary circulating tumor cell and circulating tumor DNA tests utilizing a standard blood sample.